Procedures

WWARN is continually updating a library of standardised procedures that offer guidance in the execution of various activities in the fields of clinical, in vitro, pharmacology, data collection and molecular analysis for antimalarial drug resistance researchers. Please read our tools and resources usage guidance.

For resources that relate to other infectious and emerging diseases, visit iddo.org.

Publication Code: QA03

A process for sites for identifying, documenting and reporting non-compliance during a clinical trial

Version: 2.0

Author(s): WWARN

Publication Code: DMSTAT02

Construction, security and backup of a clinical database

Version: 2.0

Author(s): WWARN

Publication Code: QA02

A process for authorship, review, authorisation, issue and control of standard operating procedures by a site

Version: 2.0

Author(s): WWARN

Publication Code: QA07

A process for assessing the risk of an institutional team conducting a trial

Version: 2.0

Author(s): WWARN

Publication Code: SAF03

A process for dealing with inadvertent exposure to potentially infectious fluids during a clinical trial

Version: 2.0

Author(s): WWARN

Publication Code: SAF05

A process for managing medical emergencies in trial participants at field sites

Version: 2.0

Author(s): WWARN

Publication Code: SAF02

A process for safely evacuating a patient due to a medical emergency from the clinical trial facility

Version: 2.0

Author(s): WWARN

Publication Code: INV11

This procedure describes two assays to evaluate the susceptibility of Plasmodium falciparum to piperaquine.

Version: V1.0

Publication Code: CLI19

Version: v1.0